[1]郝雪玮,王康,杨慧宇.富含半胱氨酸的酸性分泌蛋白在心血管疾病中的研究进展[J].国际心血管病杂志,2023,06:346-349.
点击复制
富含半胱氨酸的酸性分泌蛋白在心血管疾病中的研究进展(PDF)
《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]
- 期数:
- 2023年06期
- 页码:
- 346-349
- 栏目:
- 综述
- 出版日期:
- 2023-11-20
文章信息/Info
- Title:
- -
- Author(s):
- -
- 关键词:
- 富含半胱氨酸的酸性分泌蛋白; 高血压; 冠状动脉粥样硬化性心脏病; 心力 衰竭; 心肌炎
- Keywords:
- -
- 分类号:
- -
- DOI:
- 10.3969/j.issn.1673-6583.2023.06.003
- 文献标识码:
- -
- 摘要:
- 富含半胱氨酸的酸性分泌蛋白（SPARC）为典型的基质细胞蛋白，参与组织发 育和修复，通过调节细胞黏附、增殖和生长因子信号转导，以及细胞外基质与细胞的相互作用， 在心肌损伤过程发挥重要作用。该文介绍SPARC 在高血压、冠状动脉粥样硬化性心脏病、 心力衰竭、病毒性心肌炎等心血管疾病中的相关研究进展。
- Abstract:
- -
参考文献/References
[1] Motamed K. SPARC (osteonectin/BM-40)[J]. Int J Biochem
Cell Biol, 1999, 31(12):1363-1366.
[2] Termine JD, Kleinman HK, Whitson SW, et al. Osteonectin,
a bone-specific protein linking mineral to collagen[J]. Cell,
1981, 26(1 Pt 1):99-105.
[3] Xiao C, Jin HG, Zhang LC, et al. Effects of SPARCL1 on the
proliferation and differentiation of sheep preadipocytes[J].
Adipocyte, 2021, 10(1):658-669.
[4] Liu B, Xiang L, Ji J, et al. Sparcl1 promotes nonalcoholic
steatohepatitis progression in mice through upregulation of
CCL2[J]. J Clin Invest, 2021, 131(20):e144801.
[5] Avolio E, Mangialardi G, Slater SC, et al. Secreted protein
acidic and cysteine rich matricellular protein is enriched in the
bioactive fraction of the human vascular pericyte secretome[J].Antioxid Redox Signal, 2021, 34(15):1151-1164.
[6] Wang L, Zhang Y, Yu M, et al. Identification of hub genes
in the remodeling of non-infarcted myocardium following
acute myocardial infarction[J]. J Cardiovasc Dev Dis, 2022,
9(12):409.
[7] Wang LY, Zhang YT, Du LQ, et al. The effect of SPARC on
the proliferation and migration of limbal epithelial stem cells
during the corneal epithelial wound healing[J]. Stem Cells
Dev, 2021, 30(6):301-308.
[8] Chen S, Zou Q, Chen Y, et al. Regulation of SPARC family
proteins in disorders of the central nervous system[J]. Brain
Res Bull, 2020, 163:178-189.
[9] Ghanemi A, Melouane AC, Yoshioka MYI, et al. Exercise
and high-fat diet in obesity: functional genomics perspectives
of two energy homeostasis pillars[J]. Genes (Basel), 2020,
11(8):875.
[10] Ghanemi A, Melouane A, Yoshioka M, et al. Exercise training
of secreted protein acidic and rich in cysteine (Sparc) KO mice
suggests that exercise-induced muscle phenotype changes are
SPARC-dependent[J]. Appl Sci, 2020, 10(24):9108.
[11] Atorrasagasti C, Onorato A, Gimeno ML, et al. SPARC
is required for the maintenance of glucose homeostasis
and insulin secretion in mice[J]. Clin Sci (Lond), 2019,
133(2):351-365.
[12] Hu L, He FL, Huang MF, et al. SPARC promotes insulin
secretion through down-regulation of RGS4 protein in
pancreatic β cells[J]. Sci Rep, 2020, 10(1):17581.
[13] Ghanemi A, Yoshioka M, St-Amand J. Secreted protein acidic
and rich in cysteine: metabolic and homeostatic properties
beyond the extracellular matrix structure[J]. Appl Sci, 2020,
10(7):2388.
[14] Ghanemi A, Melouane A, Yoshioka M, et al. Secreted protein
acidic and rich in cysteine and bioenergetics: extracellular
matrix, adipocytes remodeling and skeletal muscle
metabolism[J]. Int J Biochem Cell Biol, 2019, 117:105627.
[15] Ghanemi A, Yoshioka M, St-Amand J. Secreted protein acidic
and rich in cysteine as a regeneration factor: beyond the tissue
repair[J]. Life (Basel), 2021, 11(1):38.
[16] Riley HJ, Bradshaw AD. The influence of the extracellular
matrix in inflammation: findings from the SPARC-null
mouse[J]. Anat Rec (Hoboken), 2020, 303(6):1624-1629.
[17] Ghanemi A, Yoshioka M, St-Amand J. Secreted protein acidic
and rich in cysteine and inflammation: another homeostatic
property?[J]. Cytokine, 2020, 133:155179.
[18] Ghanemi A, Yoshioka M, St-Amand J. Secreted protein acidic
and rich in cysteine and cancer: a homeostatic hormone?[J].
Cytokine, 2020, 127:154996.
[19] Bao JM, Dang Q, Lin CJ, et al. SPARC is a key mediator of
TGF-β-induced renal cancer metastasis[J]. J Cell Physiol,
2021, 236(3):1926-1938.
[20] Camacho D, Jesus JP, Palma AM, et al. SPARC-p53: the
double agents of cancer[J]. Adv Cancer Res, 2020, 148:171-
199.
[21] Atorrasagasti C, Onorato AM, Mazzolini G. The role of
SPARC (secreted protein acidic and rich in cysteine) in the
pathogenesis of obesity, type 2 diabetes, and non-alcoholic
fatty liver disease[J]. J Physiol Biochem, 2022. [Epub ahead
of print].
[22] M Onorato A, Fiore E, Bayo J, et al. SPARC inhibition
accelerates NAFLD-associated hepatocellular carcinoma
development by dysregulating hepatic lipid metabolism[J].
Liver Int, 2021, 41(7):1677-1693.
[23] Schellings MWM, Vanhoutte D, Swinnen M, et al. Absence of
SPARC results in increased cardiac rupture and dysfunction
after acute myocardial infarction[J]. J Exp Med, 2009,
206(1):113-123.
[24] 李芳, 郝杰, 刘金明, 等. 原发性高血压老年患者血清富
含半胱氨酸酸性分泌蛋白、DFR、半乳糖凝集素-3与颈
动脉粥样硬化的相关性分析[J]. 老年医学与保健, 2021,
27(6):1239-1242.
[25] 李娜, 张岩, 贾营, 等. 血清SPARC和RBP-4在老年高血压
患者中的表达及临床意义[J]. 临床误诊误治, 2021, 34(9):
55-60.
[26] 李娜, 张岩, 贾营. 血清RBP-4及SPARC对原发性高血压
患者动脉粥样硬化的预测效果[J]. 临床和实验医学杂志,
2022, 21(2):150-154.
[27] Toba H, Ikemoto MJ, Kobara M, et al. Secreted protein
acidic and rich in cysteine (SPARC) and a disintegrin
and metalloproteinase with thrombospondin type 1 motif
(ADAMTS1) increments by the renin-angiotensin system
induce renal fibrosis in deoxycorticosterone acetate-salt
hypertensive rats[J]. Eur J Pharmacol, 2022, 914:174681.
[28] Takahashi M, Nagaretani H, Funahashi T, et al. The expression
of SPARC in adipose tissue and its increased plasma
concentration in patients with coronary artery disease[J]. Obes
Res, 2001, 9(7):388-393.
[29] Myasoedova VA, Chistiakov DA, Grechko AV, et al.
Matrix metalloproteinases in pro-atherosclerotic arterial
remodeling[J]. J Mol Cell Cardiol, 2018, 123:159-167.
[30] Ragino YI, Kashtanova EV, Chernjavski AM, et al. Blood
level of osteonectin in stenosing atherosclerosis and calcinosis
of coronary arteries[J]. Bull Exp Biol Med, 2011, 151(3):
370-373.
[31] Lindsey ML, Zamilpa R. Temporal and spatial expression
of matrix metalloproteinases and tissue inhibitors of
metalloproteinases following myocardial infarction[J].
Cardiovasc Ther, 2012, 30(1):31-41.
[32] McClung HM, Thomas SL, Osenkowski P, et al. SPARC
upregulates MT1-MMP expression, MMP-2 activation, and
the secretion and cleavage of galectin-3 in U87MG glioma
cells[J]. Neurosci Lett, 2007, 419(2):172-177.
[33] Riley HJ, Kelly RR, Van Laer AO, et al. SPARC production by
bone marrow-derived cells contributes to myocardial fibrosis
in pressure overload[J]. Am J Physiol Heart Circ Physiol,2021, 320(2):H604-H612.
[34] Zhou S, Lei D, Bu F, et al. MicroRNA-29b-3p targets SPARC
gene to protect cardiocytes against autophagy and apoptosis in
hypoxic-induced H9c2 cells[J]. J Cardiovasc Transl Res, 2019,
12(4):358-365.
[35] Xia N, Lu Y, Gu M, et al. A unique population of regulatory T
cells in heart potentiates cardiac protection from myocardial
infarction[J]. Circulation, 2020, 142(20):1956-1973.
[36] Horn MA, Graham HK, Richards MA, et al. Age-related
divergent remodeling of the cardiac extracellular matrix in
heart failure: collagen accumulation in the young and loss in
the aged[J]. J Mol Cell Cardiol, 2012, 53(1):82-90.
[37] Berezin AE, Kremzer AA. Predictive value of circulating
osteonectin in patients with ischemic symptomatic chronic
heart failure[J]. Biomed J, 2015, 38(6):523-530.
[38] Pollack A, Kontorovich AR, Fuster V, et al. Viral
myocarditis—diagnosis, treatment options, and current
controversies[J]. Nat Rev Cardiol, 2015, 12(11):670-680.
[39] Rienks M, Carai P, van Teeffelen J, et al. SPARC preserves
endothelial glycocalyx integrity, and protects against adverse
cardiac inflammation and injury during viral myocarditis[J].
Matrix Biol, 2018, 74:21-34.
[40] Deckx S, Johnson DM, Rienks M, et al. Extracellular SPARC
increases cardiomyocyte contraction during health and
disease[J]. PLoS One, 2019, 14(4):e0209534.
备注/Memo
- 备注/Memo:
-
基金项目：国家自然科学基金（81700407）；2022 年度“四个一批”
科技兴医创新计划（2022XM08）
通信作者：杨慧宇， E-mail：yanghuiyu2010@126.com
常用功能
统计/Statistics
- 摘要浏览/Viewed98
- 全文下载/Downloads322
- 评论/Comments
